药房斗争,因为PBM对处方收费不足,促使国家进行改革,以保护获得药物的机会。 Pharmacies struggle as PBMs underpay for prescriptions, prompting state reforms to protect access to medications.

美国各地的药店都面临财政困难,因为药房福利经理(PBMs)对处方的付款不足,导致关闭药店和减少药品供应。 Pharmacies across the U.S. are facing financial struggles due to pharmacy benefit managers (PBMs) underpaying for prescriptions, leading to closures and reduced access to medications. 爱荷华州和阿拉巴马州等国家正在推动立法改革PBM做法,目的是防止药房获得低于药品成本的报销,并停止引导病人离开独立的药房。 States like Iowa and Alabama are pushing legislation to reform PBM practices, aiming to prevent pharmacies from being reimbursed less than the drug's cost and to stop steering patients away from independent pharmacies. 然而,有人警告说,这种改革可能会提高消费者的药物价格。 However, some warn that such reforms could raise drug prices for consumers. 在宾夕法尼亚州,自2024年1月以来关闭了近200家药店,倡导者呼吁采取更多的联邦干预措施,解决药品成本和PBM做法问题。 In Pennsylvania, nearly 200 pharmacies have closed since January 2024, and advocates are calling for more federal intervention to address pharmaceutical costs and PBM practices.